Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/16/10 → 2/28/11 |
Funding
- Parexel International Co: $13,772.00
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIb Study to Compare the Efficacy and Safety of Two or Three Dosing Regimens of Intravenous Infusions of Cytofab (AZD9773) in Adult Patients with Sepsis
- Bernard, Andrew (PI)